By Topic

Automated image-based phenotypic screening for high-throughput drug discovery

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

6 Author(s)
Rahul Singh ; Department of Computer Science, San Francisco State University, San Francisco CA 94132 ; Michalis Pittas ; Ido Heskia ; Fengyun Xu
more authors

At the state-of-the-art in drug discovery, one of the key challenges is to develop high-throughput screening (HTS) techniques that can measure changes as a continuum of complex phenotypes induced in a target pathogen. Such measurements are crucial in developing therapeutics against diseases like schistosomiasis, trypanosomiasis, and leishmaniasis, which impact millions worldwide. These diseases are caused by parasites that can manifest a variety of phenotypes at any given point in time in response to drugs. Consequently, a single end-point measurement of 'live or death' (e.g., ED50 value) commonly used for lead identification is over-simplistic. In our method to address this problem, the parasites are tracked during the entire course of (video) recorded observations and changes in their appearance-based and behavioral characteristics quantified using geometric, texture-based, color-based, and motion-based descriptors. Subsequently, within the on-line setting, machine learning techniques are used classify the exhibited phenotypes into well defined categories. Important advancements introduced as a consequence of the proposed approach include: (1) ability to assess the interactions between putative drugs and parasites in terms of multiple appearance and behavior-based phenotypes, (2) automatic classification and quantification of pathogen phenotypes. Experimental data from lead identification studies against the disease Schistosomiasis validate the proposed methodology.

Published in:

Computer-Based Medical Systems, 2009. CBMS 2009. 22nd IEEE International Symposium on

Date of Conference:

2-5 Aug. 2009